Direct intercalation of bis-2,2',2″,6-terpyridylcobalt(III) into zirconium phosphate layers for biosensing applications.

The direct intercalation reaction of [Co(tpy)(2)](2+) with the highly hydrated θ phase of layered zirconium phosphate (θ-ZrP) resulted in the formation of the oxidized [Co(tpy)(2)](3+) ion within the ZrP material. The X-ray powder diffraction patterns showed that the interlayer distance increases from 10.3 Å in θ-ZrP to 14.9 Å in the dry [Co(tpy)(2)](3+)-intercalated ZrP {[Co(tpy)(2)](3+):ZrP} phase. The complex remains electroactive within the layers of ZrP. The formal potential of a carbon paste electrode (CPE) modified with [Co(tpy)(2)](3+):ZrP (E°' = 40.8 mV versus Ag/AgCl, 3.5 M NaCl) is non-pH-dependent. However, the sensitivity of the [Co(tpy)(2)](3+):ZrP-modified CPE for the detection of reduced nicotinamide adenine dinucleotide (NADH) electrooxidation was lower than that of a previously reported CPE modified with [Ru(phend)(2)bpy](2+)-intercalated ZrP. (1) To improve the characteristics of NADH electrooxidation of the [Co(tpy)(2)](3+):ZrP-modified CPE, we included the enzyme diaphorase in solution, which increased the electrocatalytic current for NADH oxidation. A bienzymatic lactate biosensor was constructed and used for lactate sensing.

Prediction of warfarin dose reductions in Puerto Rican patients, based on combinatorial CYP2C9 and VKORC1 genotypes.

BACKGROUND: The influence of CYP2C9 and VKORC1 polymorphisms on warfarin dose has been investigated in white, Asian, and African American populations but not in Puerto Rican Hispanic patients. OBJECTIVE: To test the associations between genotypes, international normalized ratio (INR) measurements, and warfarin dosing and gauge the impact of these polymorphisms on warfarin dose, using a published algorithm. METHODS: A retrospective warfarin pharmacogenetic association study in 106 Puerto Rican patients was performed. DNA samples from patients were assayed for 12 variants in both CYP2C9 and VKORC1 loci by HILOmet PhyzioType assay. Demographic and clinical nongenetic data were retrospectively collected from medical records. Allele and genotype frequencies were determined and Hardy-Weinberg equilibrium (HWE) was tested. RESULTS: Sixty-nine percent of patients were carriers of at least one polymorphism in either the CYP2C9 or the VKORC1 gene. Double, triple, and quadruple carriers accounted for 22%, 5%, and 1%, respectively. No significant departure from HWE was found. Among patients with a given CYP2C9 genotype, warfarin dose requirements declined from GG to AA haplotypes; whereas, within each VKORC1 haplotype, the dose decreased as the number of CYP2C9 variants increased. The presence of these loss-of-function alleles was associated with more out-of-range INR measurements (OR = 1.38) but not with significant INR >4 during the initiation phase. Analyses based on a published pharmacogenetic algorithm predicted dose reductions of up to 4.9 mg/day in carriers and provided better dose prediction in an extreme subgroup of highly sensitive patients, but also suggested the need to improve predictability by developing a customized model for use in Puerto Rican patients. CONCLUSIONS: This study laid important groundwork for supporting a prospective pharmacogenetic trial in Puerto Ricans to detect the benefits of incorporating relevant genomic information into a customized DNA-guided warfarin dosing algorithm.

Layered inorganic materials as redox agents: ferrocenium-intercalated zirconium phosphate.

The direct intercalation reaction of ferrocene (bis(eta5-cyclopentadienyl)iron(II), Fc) with a highly hydrated layered zirconium phosphate (ZrP) resulted in the formation of the ferrocenium ion (Fc+) within the ZrP material. The Fc+-intercalated ZrP material has an interlayer distance of 10.7 A. The intercalated material was used as an electron acceptor for the oxidation of both ferro-cytochrome c and the excited state of tris(2,2'-bipyridine)ruthenium(II) ([Ru(bpy)3]2+). Upon contact of the material with a 1.5 x 10(-5) M solution of ferro-cytochrome c, the UV-vis absorption spectrum shows the successful formation of ferri-cytochrome c. Luminescence spectroscopy shows that the Fc+-intercalated ZrP material quenches the luminescence of [Ru(bpy)3]2+. The excited-state quenching mechanism of [Ru(bpy)3]2+* by Fc+-intercalated ZrP follows a dynamic plus sphere of action model. The second-order dynamic quenching rate constant kq is 2.2 x 10(8) M(-1) s(-1).

NADH Electrooxidation Using Bis(1,10-phenanthroline-5,6-dione) (2,2'-bipyridine)ruthenium(II)-Exchanged Zirconium Phosphate Modified Carbon Paste Electrodes.

We present a carbon paste electrode (CPE) modified using the electron mediator bis(1,10-phenanthroline-5,6-dione) (2,2'-bipyridine)ruthenium(II) ([Ru(phend)(2)bpy](2+)) exchanged into the inorganic layered material zirconium phosphate (ZrP). X-Ray powder diffraction showed that the interlayer distance of ZrP increases upon [Ru(phend)(2)bpy](2+) intercalation from 10.3 Å to 14.2 Å. The UV-vis and IR spectroscopies results showed the characteristic peaks expected for [Ru(phend)(2)bpy](2+). The UV-vis spectrophotometric results indicate that the [Ru(phend)(2)bpy](2+) concentration inside the ZrP layers increased as a function of the loading level. The exchanged [Ru(phend)(2)bpy](2+) exhibited luminescence even at low concentration. Modified CPEs were constructed and analyzed using cyclic voltammetry. The intercalated mediator remained electroactive within the layers (E°' = -38.5 mV vs. Ag/AgCl, 3.5 M NaCl) and electrocatalysis of NADH oxidation was observed. The kinetics of the modified CPE shows a Michaelis -Menten behavior. This CPE was used for the oxidation of NADH in the presence of Bakers' yeast alcohol dehydrogenase. A calibration plot for ethanol is presented.